MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Laboratory Corporation of America Holdings ROCE Ratio 2011-2026 | LH
Annual ROCE Ratio Laboratory Corporation of America Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16.06 | 13.5 | 9.21 | 14.23 | 29.67 | 25.91 | 9.0 | 9.6 | 9.88 | 11.04 | 8.92 | 14.67 | 16.25 | 18.19 | 19.28 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 29.67 | 8.92 | 15.03 |
Quarterly ROCE Ratio Laboratory Corporation of America Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 3.71 | 7.41 | 11.53 | 14.24 | 21.48 | 25.01 | 27.71 | 24.53 | 35.72 | 39.67 | 36.03 | 12.31 | 16.71 | 10.02 | 11.27 | 17.53 | 17.5 | 17.93 | 18.79 | 18.97 | 16.89 | 14.22 | 11.2 | 9.02 | 12.62 | 16.25 | 20.61 | 17.96 | 24.3 | 24.75 | 24.76 | 15.7 | 24.26 | 26.49 | 28.59 | 49.37 | 59.19 | 60.44 | 62.51 | 31.14 | 40.16 | 39.37 | 38.71 | 29.74 | 39.3 | 39.85 | 38.71 | 28.0 | 9.56 | 9.02 | 9.42 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 62.51 | 3.71 | 24.71 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
25.0 | $ 114.84 | -0.55 % | $ 34.9 B |  USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 16.3 | 0.62 % | $ 175 M |  China |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
|
Biodesix
BDSX
|
-41.6 | $ 15.36 | 1.92 % | $ 1.99 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
6.33 | $ 27.2 | 0.33 % | $ 20 B |  Niderland |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | Niderland |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 17.82 | -2.68 % | $ 950 M | USA |
 |
Anixa Biosciences
ANIX
|
-77.18 | $ 2.59 | 1.57 % | $ 84.1 K | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.17 | - | $ 4.98 M | USA |
 |
BioNano Genomics
BNGO
|
-75.05 | $ 1.15 | -4.17 % | $ 6.26 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M |  Israel |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 168.22 | -3.26 % | $ 8.34 B | USA |
 |
Castle Biosciences
CSTL
|
1.9 | $ 24.73 | -0.44 % | $ 687 M | USA |
 |
Celcuity
CELC
|
-171.24 | $ 114.22 | 1.41 % | $ 5.34 B | USA |
 |
Danaher Corporation
DHR
|
8.93 | $ 192.12 | 0.53 % | $ 137 B | USA |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
DexCom
DXCM
|
33.2 | $ 63.21 | 1.59 % | $ 24.7 B | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 198.96 | 0.91 % | $ 22.1 B | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 16.42 | -2.38 % | $ 496 M | USA |
 |
Guardant Health
GH
|
440.3 | $ 89.66 | -4.44 % | $ 11.2 B | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 109.62 | -4.0 % | $ 9.04 B |  Irlanda |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 1.97 | 0.63 % | $ 8.72 M | USA |
 |
Illumina
ILMN
|
-35.1 | $ 127.74 | 0.28 % | $ 20.3 B | USA |
 |
IQVIA Holdings
IQV
|
33.55 | $ 170.72 | -1.47 % | $ 29.3 B | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 75.89 | -0.28 % | $ 5.12 B | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 496.0 | -0.47 % | $ 14.3 B | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 266.63 | 0.53 % | $ 26.1 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 4.67 | -1.68 % | $ 432 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-185.74 | $ 4.74 | 1.07 % | $ 3.73 M | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 8.02 | 0.25 % | $ 1.03 B | USA |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 9.56 | 1.59 % | $ 2.07 B | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 17.33 | 0.99 % | $ 388 M | USA |